Med-Chemist : "Quintessential Medicinal Chemistry"
Saturday, April 9, 2011
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
In continuation of my update on
Vandetanib
,,,,,
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment